Hormones Found to Regulate Human Retinal Development
The discovery clarifies how central vision develops and may point toward new treatments for macular degeneration.
Updated on Oct. 31, 2026 in Nutrition
Live Poll
Do you believe scientists will successfully develop vision-restoration treatments for eye diseases in your lifetime?
Scientists have discovered that retinoic acid and thyroid hormones are essential for regulating the development of light-sensitive cones in the human retina. This finding challenges existing theories about how our central vision forms and may eventually guide new regenerative therapies for eye diseases.
Why it matters
Understanding how the foveola develops is critical because this small area of the retina supports approximately 50 percent of human visual perception. By identifying the hormonal triggers for cell specialization, researchers are creating a roadmap for potentially repairing retinas damaged by conditions like macular degeneration.
In a study using laboratory-grown human retinal organoids, researchers observed that specific hormones govern photoreceptor development. These preliminary findings clarify the cellular formation of the central retina, though the long-term efficacy of using these cells for clinical transplantation is unknown.
The players
Johns Hopkins University
A leading research institution focused on advanced biomedical science and organoid development.
The details
The development of the foveola involves a precise hormonal dance where retinoic acid acts to limit the formation of blue-sensitive cones in the central retina. Simultaneously, thyroid hormones promote the transformation of these early-stage blue-sensitive cells into red- and green-sensitive cones by the 14th week of fetal development. This mechanism contradicts the older theory that blue-sensitive cones simply migrate away from the foveola as the eye matures.
Timeline
10th to 12th weeks of fetal development: Blue-sensitive cones appear in the foveola.
14th week of fetal development: Blue-sensitive cones develop into red- and green-sensitive cones.
Health Landscape
This research provides a foundational framework that advances the field of retinal organoid development. By mapping these specific signaling pathways, science moves closer to the historical goal of creating specialized photoreceptors for clinical use in patients with degenerative eye conditions.
While these findings offer hope for future treatments, it is important to note that vitamin A supplements do not improve vision in adults and should not be taken for that purpose. If you are concerned about vision changes or macular health, discuss potential screening and preventive care options with your ophthalmologist.
The takeaway
The development of central vision is a complex, hormone-regulated process rather than a simple cell migration event. Stay informed on ocular health by prioritizing regular comprehensive eye exams with your physician to monitor for early signs of macular degeneration or glaucoma.
Further reading
Learn more about the components of ocular health in our Nutrition section.
Source note: This article includes information reported by Bangladeshpost.
Live Poll
Do you believe scientists will successfully develop vision-restoration treatments for eye diseases in your lifetime?
